HomeNewsBusinessEconomyIndia's exports rise 67% in May on low base effect, imports surge by 68.5%

India's exports rise 67% in May on low base effect, imports surge by 68.5%

The headline numbers jumped high due to a severely low base as trade had crashed during May, 2020 when the COVID-induced lockdown was in full swing. But citing a nearly 8 percent growth after comparing with May, 2019, the government has expressed confidence that exports are well on their way towards recovery.

June 02, 2021 / 15:44 IST
Story continues below Advertisement
All major export segments such as processed petroleum, electronics, engineering  goods, gems & jewellery, textiles and pharma saw major growth in April. (Representative image)
All major export segments such as processed petroleum, electronics, engineering goods, gems & jewellery, textiles and pharma saw major growth in April. (Representative image)

India's merchandise exports shot up by 67.3 percent year-on-year (YoY) in May owing to a large base effect, after a rise of 193.3 percent in April. However, comparisons with May, 2019 showed exports have grown by 7.9 percent, indicating real recovery in the sector.

Preliminary data released by the Commerce and Industry Ministry on June 2 showed outbound trade rose to $32.2 billion in May, 2021 from $19.4 billion in April, 2020 when the COVID-induced lockdown was in full force.

Story continues below Advertisement

However, the government drew attention to the fact that latest figures comfortably surpass those of May, 2019 as well, which is considered a normal export year, when exports stood at $29.85 billion.

The large rise over the past year is attributable to the extremely low volume of trade in 2020 due to the nationwide lockdown. However, the rise vis-a-vis 2019, is due to the opening up of key overseas markets such as the United States and European Union and the high global pries of commodities.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show